These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4276661)

  • 1. Proceedings: The effects of cardiac glycosides on Ca-mediated action potentials in the mammalian myocardium.
    Tritthart H; Weiss R; Volkmann R; Späh F
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R99. PubMed ID: 4276661
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of six cardiac glycosides on the transmembrane potential and contractile characteristics of the right ventricle of guinea pigs.
    Ito M; Hollander PB; Marks BH; Dutta S
    J Pharmacol Exp Ther; 1970 Mar; 172(1):188-95. PubMed ID: 5416942
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heart function in hyperthyroidism].
    Lüderitz B
    Internist (Berl); 1975 Nov; 16(11):524-9. PubMed ID: 1104512
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative studies on the cardiotonic action of corchoroside A, ouabain and strophanthin K on the heart-lung preparation of guinea pig and cat (author's transl)].
    Rao MR; Liu TP; Meng ZJ
    Yao Xue Xue Bao; 1979; 14(5):257-66. PubMed ID: 506725
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cardiac glycosides on interaction of Ca++ with mitochondria.
    Lee KS; Hong SA; Kang DH
    J Pharmacol Exp Ther; 1970 Mar; 172(1):180-7. PubMed ID: 5416941
    [No Abstract]   [Full Text] [Related]  

  • 6. Relative inotropic and arrhythmogenic effects of five cardiac steroids in ventricular myocardium: oscillatory afterpotentials and the role of endogenous catecholamines.
    Karagueuzian HS; Katzung BG
    J Pharmacol Exp Ther; 1981 Aug; 218(2):348-56. PubMed ID: 6114168
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of therapeutic and toxic concentrations of cardiotonics on the reactivity of an isolated preparation to chemical mediators and on its ionic content].
    Godfraind T; Burton J
    J Physiol (Paris); 1967; 59(4 Suppl):411-2. PubMed ID: 5608762
    [No Abstract]   [Full Text] [Related]  

  • 8. [Species sensitivity to cardiac glycosides (a review of the literature)].
    Mironova MI; Bulenkov TI
    Farmakol Toksikol; 1977; 40(5):630-6. PubMed ID: 336389
    [No Abstract]   [Full Text] [Related]  

  • 9. [Certain problems of pharmacodynamics, pharmacokinetics and the use of cardiac glycosides].
    Kukes VG; Volkov RIu
    Kardiologiia; 1977 Sep; 17(9):135-42. PubMed ID: 144820
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inotropic action of cardiac glycosides in light of current conceptions of electromechanical coupling in the myocardium].
    Izakov VF; Markhasin VS; Tsyv'ian PB
    Usp Fiziol Nauk; 1979; 10(2):73-6. PubMed ID: 224611
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined effect of cardiac glycosides and diuretics of some functions of heart].
    Zhukova VA
    Farmakol Toksikol; 1969; 32(6):690-2. PubMed ID: 5381599
    [No Abstract]   [Full Text] [Related]  

  • 12. The subcellular basis for the mechanism of inotropic action of cardiac glycosides.
    Lee KS; Klaus W
    Pharmacol Rev; 1971 Sep; 23(3):193-261. PubMed ID: 4255625
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cellular mechanisms of the inotropic action of cardiac glycosides].
    Beresewicz A
    Kardiol Pol; 1974; 17(3):267-73. PubMed ID: 4276789
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of oleic acid on the interaction of some cardioactive glycosides with serum albumin, and cardiac actin and myosin].
    Pagnini G; Granato Corigliano G; Di Carlo R; Santamaria R; Genazzani E
    Boll Soc Ital Biol Sper; 1968 Dec; 44(23):2003-6. PubMed ID: 5735768
    [No Abstract]   [Full Text] [Related]  

  • 15. [Basis of the active mechanism of cardioactive glycoside].
    Schoner W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():6-18. PubMed ID: 148185
    [No Abstract]   [Full Text] [Related]  

  • 16. [The mechanism of action of cardiac glycosides].
    Schatzmann HJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):12-23. PubMed ID: 4240935
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative effect of erychroside and strophanthin on the intensity of coronary blood flow].
    Liubetskaia ZhA; Bezruk PI; Angarskaia MA
    Farmakol Toksikol; 1966; 29(2):180-3. PubMed ID: 6000341
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of cardiac glycosides on isoprenaline-induced heart changes].
    Staneva-Stoĭcheva D; Maĭnkhard P
    Eksp Med Morfol; 1976; 15(2):74-8. PubMed ID: 1278083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil blockade of slow Na+ and Ca++ responses in myocardial cells.
    Shigenobu K; Schneider JA; Sperelakis N
    J Pharmacol Exp Ther; 1974 Aug; 190(2):280-8. PubMed ID: 4375179
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: The influence of cardiac glycosides on membrane currents in mammalian myocardium.
    Nawrath H; McDonald TF; Trautwein W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R24. PubMed ID: 1143408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.